Form 8-K - Current report:
SEC Accession No. 0001140361-25-029350
Filing Date
2025-08-07
Accepted
2025-08-07 07:40:52
Documents
17
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20053240_8k.htm   iXBRL 8-K 33559
2 EXHIBIT 99.1 ef20053240_ex99-1.htm EX-99.1 239784
7 image00002.jpg GRAPHIC 3255
8 image00004.jpg GRAPHIC 3387
9 image00005.jpg GRAPHIC 3413
  Complete submission text file 0001140361-25-029350.txt   482205

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imcr-20250807.xsd EX-101.SCH 4331
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imcr-20250807_def.xml EX-101.DEF 17570
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20250807_lab.xml EX-101.LAB 26449
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20250807_pre.xml EX-101.PRE 19755
20 EXTRACTED XBRL INSTANCE DOCUMENT ef20053240_8k_htm.xml XML 6467
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 251191652
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)